Activity of crizotinib in relapsed MET amplified malignancies: Results of the French AcSé Program. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results